ID Consultant
Hippokration Hospital Thessaloniki, Greece
Disclosure(s): Gilead: Honoraria; Pfizer: Honoraria
QUALIFICATIONS
May 2017 Specialist in Infectious Diseases
Feb 2010 Specialist in Internal Medicine
Oct 2001 Medical Degree (MB BS equivalent)
Apr 1997 PhD in Cell Biology/ Biochemistry
July 1992 Bachelor of Science (Biology)
CURRENT POSTS
Feb 2011 – present Consultant in Internal Medicine, Hippokration Hospital, Thessaloniki
(Sep 2020 – Dec 2020 Scientific Director of the COVID Dept, ID specialist since May 2017)
Member of ESCMID
Member of IDSA
RESEARCH
Jan 2009 - Jan 2010 Postdoctoral research (Lab of the 2nd Prop Dept of Internal Medicine, Aristotle Univ of Thessaloniki) (postdoctoral excellence award 2009) “Response of rheumatoid arthritis to rituximab: characterization of response biomarkers”
Feb 2000–Oct 2001 Postdoctoral research (Lab of Pathology, Aristotle Univ of Thessaloniki). “Electromagnetic field - induced changes in the expression of bone morphogenetic proteins in the kidney and lung of the rat embryo”.
Sept 1993–Dec 1996 PhD Thesis (Dept of Cell Biology, EMBL, Heidelberg, Germany). (EMBL fellowship) “Interactions of the nuclear envelope with chromatin: Reformation of the nuclear envelope at the end of mitosis”.
Participation in 19 clinical studies as Sub-Investigator since 2005
Publications in peer reviewed journals: 76, Google Scholar citations: 2140, h-index: 25, IF>150